Several of our recent Life Sciences podcasts have featured conversations about the rapid shifts taking place in this dynamic industry. Automation and information management technology are rapidly advancing to help address these challenges. In a recent Emerson...
In the life sciences, bringing treatments to market quicker is no longer a bonus. Today, accelerating the treatment development pipeline is an expectation—arguably a core value—of the world’s most respected pharmaceutical companies. The pipeline for the COVID vaccine...
Process manufacturing organizations have always needed to optimize operations, but the underlying catalysts for that need have not always been static. Today, for example, optimization is very much a result of increasing globalization and the need to secure competitive...
Most people have heard the adage that, “COVID changed everything.” However, few people, when presented with that idea, think that any of those changes were positive. But we often forget that in the span of eight short months, the world saw a wide array of innovators...
The rapid shift to more sustainable industrial operations has dramatically impacted the hydrocarbon processing industry. It seems like almost overnight, operations teams are looking at entirely new processes focused on manufacturing new, greener alternative products...
It can be hard to keep up with the many rapid changes occurring in the life sciences industry these days. In an effort to embrace improved speed to market, sustainability, and quality, life sciences manufacturers are employing a wide range of software and technologies...
At Emerson, we find ourselves in a unique position. Like many companies, we’re committing to a future of more sustainable operations, starting with a goal of net zero greenhouse gas emissions by 2045. But Emerson also has an opportunity—and an obligation—not many...
At the 2022 ARC Industry Forum in Orlando, Emerson’s Process Systems & Software President, Nathan Pettus joined an executive panel moderated by ARC Advisory Group President and CEO Andy Chatha to share thoughts on effects of Covid on digital transformation initiatives.
The rapid development of the COVID-19 vaccine has created a dramatic shift in the way the public and life sciences organizations view the manufacturing of pharmaceuticals. In a recent Q&A with Pharma Manufacturing, Nathan Pettus, president of Emerson’s process...
Our Global Community
Emerson Exchange 365
The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.